NDC 50090-7803-01 - Doxazosin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7803
- Requested NDC
- 50090-7803-01
- Package NDCs from labels
- 50090-7803-0, 50090-7803-1, 50090-7803-2, 50090-7803-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxazosin - A-S Medication Solutions | A-S Medication Solutions | 2025-12-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7803-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | 12 | |
| 50090-7803-1 | Doxazosin | 100 in 1 BOTTLE | TABLET | 100 | 12 | |
| 50090-7803-2 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | 12 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7803-0 | EA - Each | 50090-7803 | 8f8737aa-1a18-4942-ae9f-d5ee041d5d58 | 1 | 2026-01-08 |
| 50090-7803-1 | EA - Each | 50090-7803 | 76c36871-a915-4c88-a394-d4e0ce07d864 | 1 | 2026-01-08 |
| 50090-7803-2 | EA - Each | 50090-7803 | f7f69033-4fc2-48b5-a263-f4d8c0decf20 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 368GB5141J |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Mylan Pharmaceuticals Inc. | 2e524986-7903-416f-b2b8-d27295103e75 | 2024-03-11 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 0d9df8e9-f823-4ff8-a5fe-0309dd132b04 | 2024-02-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin Mesylate | DOXAZOSIN MESYLATE | Unichem Pharmaceuticals (USA), Inc. | 44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f | 2024-01-23 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | Viatris Specialty LLC | 5e1f5e49-2da1-43ab-9795-228a8bcc5a82 | 2023-10-15 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Zydus Pharmaceuticals USA Inc. | e4758bf9-b9d4-4268-beb8-0d7e06890895 | 2023-09-16 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | BioActive Nutritional | 3382df85-3ec5-4371-830e-4ed345b8f51b | 2023-07-14 | Warnings | 368GB5141J |
| Pneumotox | TRITICUM AESTIVUM, ALFALFA, ARNICA MONTANA, ASCLEPIAS TUBEROSA, CHAMOMILLA, ECHINACEA (ANGUSTIFOLIA), EUCALYPTUS GLOBULUS, FUCUS VESICULOSUS, HORDEUM VULGARE, IODIUM, NASTURTIUM AQUATICUM, PLANTAGO MAJOR, RAPHANUS SATIVUS, TRIFOLIUM PRATENSE, TRIGONELLA FOENUM-GRAECUM, SYMPHYTUM OFFICINALE, LUNG (SUIS), ORYZA SATIVA, SILICEA, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, NATRUM MURIATICUM, NITRICUM ACIDUM, | BioActive Nutritional, Inc. | f8846fb1-92e5-4f8e-b3b3-bc620df90a62 | 2023-07-12 | Warnings | 368GB5141J |
| Doxazosin mesylate | DOXAZOSIN MESYLATE | Chartwell RX, LLC | a7f589b0-eebb-48cb-912f-a4bd956e4dcb | 2023-06-09 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura XL | DOXAZOSIN MESYLATE | Viatris Specialty LLC | 355bcdce-0481-48ba-8ebd-2009106aaf77 | 2023-05-15 | Warnings, Adverse reactions | 86P6PQK0MU |
| Petrochemical Detox | CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, SYMPHYTUM OFFICINALE, ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, ARSENICUM ALBUM, CADMIUM SULPHURATUM, GELSEMIUM SEMPERVIRENS, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PLATINUM METALLICUM, LATRODECTUS MACTANS | Deseret Biologicals, Inc. | b38b492a-cf45-4aa2-ba7e-4573d2c4ebe5 | 2023-01-12 | Warnings | 368GB5141J |
| Doxazosin | DOXAZOSIN | Proficient Rx LP | 8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d | 2022-08-01 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | b364c7a8-72b5-4776-a500-400c37a72c9b | 2022-02-03 | Warnings, Adverse reactions | 197628 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Mylan Pharmaceuticals Inc. | 6b887aa5-5edf-48c5-a480-dea8c35afa9d | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Cardura | DOXAZOSIN | ROERIG | eefc47bc-c10f-49bb-8ef7-5999f798ab39 | 2022-01-20 | Warnings, Adverse reactions | 197625 197628 197626 197627 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | f1dc70f6-4329-46da-8990-7bd6eec9d37d | 2021-12-07 | Warnings, Adverse reactions | 197628 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Teva Pharmaceuticals USA, Inc. | 0aaa68a7-f73b-46d8-860f-a76d96897489 | 2021-11-30 | Warnings, Adverse reactions | ANDA075536 0093-2068 197625 197628 197626 197627 69a65fb3-443c-4b78-bb8b-9d8feff93fed 0aaa68a7-f73b-46d8-860f-a76d96897489 86P6PQK0MU |
| Doxazosin | DOXAZOSIN MESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 6b74b18f-b89a-4109-a29e-c4fa65a3c5ee | 2020-12-10 | Warnings, Adverse reactions | 197626 86P6PQK0MU |
| Doxazosin | DOXAZOSIN | Aphena Pharma Solutions - Tennessee, LLC | 7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d | 2018-03-06 | Warnings, Adverse reactions | 197627 86P6PQK0MU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.